• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人凝血酶活性位点裂隙的功能图谱分析

Functionality map analysis of the active site cleft of human thrombin.

作者信息

Grootenhuis P D, Karplus M

机构信息

Department of Computational Medicinal Chemistry, N.V. Organon, Oss, The Netherlands.

出版信息

J Comput Aided Mol Des. 1996 Feb;10(1):1-10. doi: 10.1007/BF00124460.

DOI:10.1007/BF00124460
PMID:8786410
Abstract

The Multiple Copy Simultaneous Search methodology has been used to construct functionality maps for an extended region of human thrombin, including the active site. This method allows the determination of energetically favorable positions and orientations for functional groups defined by the user on the three-dimensional surface of a protein. The positions of 10 functional group sites are compared with those of corresponding groups of four thrombin-inhibitor complexes. Many, but not all features, of known thrombin inhibitors are reproduced by the method. The results indicate that certain aspects of the binding modes of these inhibitors are not optimal. In addition, suggestions are made for improving binding by interaction with functional group sites on the thrombin surface that are not used by the thrombin inhibitors.

摘要

多拷贝同时搜索方法已被用于构建人凝血酶扩展区域(包括活性位点)的功能图谱。该方法能够确定用户定义的官能团在蛋白质三维表面上的能量有利位置和取向。将10个官能团位点的位置与四种凝血酶 - 抑制剂复合物相应基团的位置进行比较。该方法再现了已知凝血酶抑制剂的许多(但不是全部)特征。结果表明这些抑制剂结合模式的某些方面并非最佳。此外,还提出了通过与凝血酶表面上未被凝血酶抑制剂利用的官能团位点相互作用来改善结合的建议。

相似文献

1
Functionality map analysis of the active site cleft of human thrombin.人凝血酶活性位点裂隙的功能图谱分析
J Comput Aided Mol Des. 1996 Feb;10(1):1-10. doi: 10.1007/BF00124460.
2
Refined 2.3 A X-ray crystal structure of bovine thrombin complexes formed with the benzamidine and arginine-based thrombin inhibitors NAPAP, 4-TAPAP and MQPA. A starting point for improving antithrombotics.精制的2.3A 牛凝血酶与基于苯甲脒和精氨酸的凝血酶抑制剂NAPAP、4-TAPAP和MQPA形成的X射线晶体结构。改进抗血栓药物的起点。
J Mol Biol. 1992 Aug 20;226(4):1085-99. doi: 10.1016/0022-2836(92)91054-s.
3
Inhibitor binding to thrombin: x-ray crystallographic studies.抑制剂与凝血酶的结合:X射线晶体学研究
Adv Exp Med Biol. 1993;340:27-33. doi: 10.1007/978-1-4899-2418-6_3.
4
Crystallographic analysis at 3.0-A resolution of the binding to human thrombin of four active site-directed inhibitors.对四种活性位点导向抑制剂与人类凝血酶结合情况进行的3.0埃分辨率晶体学分析。
J Biol Chem. 1991 Oct 25;266(30):20085-93.
5
Inhibition of thrombin by arginine-containing peptide chloromethyl ketones and bis chloromethyl ketone-albumin conjugates.含精氨酸的肽氯甲基酮和双氯甲基酮-白蛋白缀合物对凝血酶的抑制作用。
J Enzyme Inhib. 1995;9(1):17-27. doi: 10.3109/14756369509040678.
6
Potent thrombin inhibitors that probe the S1 subsite: tripeptide transition state analogues based on a heterocycle-activated carbonyl group.探测S1亚位点的强效凝血酶抑制剂:基于杂环活化羰基的三肽过渡态类似物。
J Med Chem. 1996 Aug 2;39(16):3039-43. doi: 10.1021/jm9603274.
7
Comparison of the structures of the cyclotheonamide A complexes of human alpha-thrombin and bovine beta-trypsin.人α-凝血酶和牛β-胰蛋白酶的环赛托酰胺A复合物结构比较。
Protein Sci. 1996 May;5(5):825-35. doi: 10.1002/pro.5560050504.
8
Design, synthesis and biological activity of novel rigid amidino-phenylalanine derivatives as inhibitors of thrombin.新型刚性脒基苯丙氨酸衍生物作为凝血酶抑制剂的设计、合成及生物活性
J Enzyme Inhib. 1995;9(1):73-86. doi: 10.3109/14756369509040682.
9
Crystal structure of two new bifunctional nonsubstrate type thrombin inhibitors complexed with human alpha-thrombin.两种新型双功能非底物型凝血酶抑制剂与人α-凝血酶复合物的晶体结构
Protein Sci. 1996 Jun;5(6):1174-83. doi: 10.1002/pro.5560050620.
10
Allosteric changes in solvent accessibility observed in thrombin upon active site occupation.凝血酶活性位点被占据后,溶剂可及性发生的变构变化。
Biochemistry. 2004 May 11;43(18):5246-55. doi: 10.1021/bi0499718.

引用本文的文献

1
Quantum and molecular dynamics study for binding of macrocyclic inhibitors to human alpha-thrombin.大环抑制剂与人α-凝血酶结合的量子和分子动力学研究
Biophys J. 2007 Jun 15;92(12):4244-53. doi: 10.1529/biophysj.106.099150. Epub 2007 Mar 23.
2
Evaluation of designed ligands by a multiple screening method: application to glycogen phosphorylase inhibitors constructed with a variety of approaches.通过多重筛选方法对设计配体进行评估:应用于采用多种方法构建的糖原磷酸化酶抑制剂。
J Comput Aided Mol Des. 2001 Jul;15(7):613-47. doi: 10.1023/a:1011945119287.
3
De novo design of molecular architectures by evolutionary assembly of drug-derived building blocks.

本文引用的文献

1
An automated method for dynamic ligand design.一种用于动态配体设计的自动化方法。
Proteins. 1995 Dec;23(4):472-90. doi: 10.1002/prot.340230403.
2
Molecular basis for the inhibition of human alpha-thrombin by the macrocyclic peptide cyclotheonamide A.大环肽环西奥酰胺A抑制人α-凝血酶的分子基础。
Proc Natl Acad Sci U S A. 1993 Sep 1;90(17):8048-52. doi: 10.1073/pnas.90.17.8048.
3
Multiple copy simultaneous search and construction of ligands in binding sites: application to inhibitors of HIV-1 aspartic proteinase.结合位点中配体的多拷贝同时搜索与构建:应用于HIV-1天冬氨酸蛋白酶抑制剂
通过药物衍生结构单元的进化组装进行分子结构的从头设计。
J Comput Aided Mol Des. 2000 Jul;14(5):487-94. doi: 10.1023/a:1008184403558.
4
Design of dimerization inhibitors of HIV-1 aspartic proteinase: a computer-based combinatorial approach.HIV-1天冬氨酸蛋白酶二聚化抑制剂的设计:一种基于计算机的组合方法。
J Comput Aided Mol Des. 2000 Feb;14(2):161-79. doi: 10.1023/a:1008146201260.
5
Comparison of two implementations of the incremental construction algorithm in flexible docking of thrombin inhibitors.凝血酶抑制剂柔性对接中增量构建算法两种实现方式的比较
J Comput Aided Mol Des. 1999 Mar;13(2):167-83. doi: 10.1023/a:1008014604433.
6
Active-site-directed 3D database searching: pharmacophore extraction and validation of hits.活性位点导向的三维数据库搜索:药效团提取与命中结果验证
J Comput Aided Mol Des. 1996 Oct;10(5):397-416. doi: 10.1007/BF00124472.
7
Computational combinatorial ligand design: application to human alpha-thrombin.计算组合配体设计:在人α-凝血酶中的应用。
J Comput Aided Mol Des. 1996 Oct;10(5):372-96. doi: 10.1007/BF00124471.
J Med Chem. 1993 Jul 23;36(15):2142-67. doi: 10.1021/jm00067a013.
4
Synthetic low-molecular weight thrombin inhibitors: molecular design and pharmacological profile.合成低分子量凝血酶抑制剂:分子设计与药理学特性
Trends Pharmacol Sci. 1993 Oct;14(10):366-76. doi: 10.1016/0165-6147(93)90095-2.
5
Crystal structure of the complex of human alpha-thrombin and nonhydrolyzable bifunctional inhibitors, hirutonin-2 and hirutonin-6.人α-凝血酶与非水解性双功能抑制剂hirutonin-2和hirutonin-6复合物的晶体结构
Proteins. 1993 Nov;17(3):252-65. doi: 10.1002/prot.340170304.
6
Strategies for inhibiting the effects of thrombin.抑制凝血酶作用的策略。
Blood Coagul Fibrinolysis. 1994 Jan;5 Suppl 1:S47-58; discussion S59-64. doi: 10.1097/00001721-199401000-00007.
7
Crystallographic structures of thrombin complexed with thrombin receptor peptides: existence of expected and novel binding modes.凝血酶与凝血酶受体肽复合物的晶体结构:预期及新结合模式的存在
Biochemistry. 1994 Mar 22;33(11):3266-79. doi: 10.1021/bi00177a018.
8
Kinetic and crystallographic studies of thrombin with Ac-(D)Phe-Pro-boroArg-OH and its lysine, amidine, homolysine, and ornithine analogs.凝血酶与Ac-(D)Phe-Pro-boroArg-OH及其赖氨酸、脒基、高赖氨酸和鸟氨酸类似物的动力学和晶体学研究。
Biochemistry. 1995 Mar 21;34(11):3750-7. doi: 10.1021/bi00011a033.
9
Structure of a retro-binding peptide inhibitor complexed with human alpha-thrombin.与人类α-凝血酶复合的反向结合肽抑制剂的结构。
J Mol Biol. 1995 Feb 10;246(1):14-20. doi: 10.1006/jmbi.1994.0060.
10
Characterization of a class of peptide boronates with neutral P1 side chains as highly selective inhibitors of thrombin.一类具有中性P1侧链的肽硼酸酯作为凝血酶高度选择性抑制剂的特性研究。
J Med Chem. 1995 Apr 28;38(9):1511-22. doi: 10.1021/jm00009a012.